CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Roflumilast as add-on Therapy in Early Cases of ARDS [Phase 2]
Summary
Phase 2 trial evaluating roflumilast as add-on therapy in early acute respiratory distress syndrome (adult).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cairo University | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED